A detailed history of Daiwa Securities Group Inc. transactions in Vericel Corp stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 190 shares of VCEL stock, worth $10,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares
190
Previous 155 22.58%
Holding current value
$10,020
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$42.25 - $53.56 $1,478 - $1,874
35 Added 22.58%
190 $8,000
Q2 2024

Aug 07, 2024

SELL
$41.71 - $52.9 $1,668 - $2,116
-40 Reduced 20.51%
155 $7,000
Q4 2023

Jan 31, 2024

BUY
$30.85 - $37.09 $6,015 - $7,232
195 New
195 $7,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.49B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.